. Venom proteins and peptides identified from Vipera ammodytes montandoni. Assignment of venomic components by crude venom intact mass profiling (method A) and bottom-up (method C). RP-HPLC fractions with low masses were additionally analyzed by intact mas profiling (method B). Peak numbers based on RP-HPLC (see Figure 4B ) and TIC (see Figure 2B) Figure S1 . Tripeptide precursor fragment of V. a. transcaucasiana peak 9. The annotated MS1 spectrum of Vat by intact mass profiling peak 9 at RT 1.74 min shows the mass of the tripeptide precursor fragment PEGPPLMEPHE. Figure S14. Cytotoxicity analysis of fractionated components from Vipera a. transcaucasiana. The in vitro cytotoxicity testing with crude venoms and fractions was performed according to the protocol of Nalbantsoy and Hempel et al. [14] . Cytotoxicity assay was performed with crude and fractionated venom components for Vipera a. transcaucasiana. Cell viability was determined by MTT assay and control was exposed to vehicle only which was taken as 100 % viability. We tested all fractions against most sensitive cells MDA-MB-231 according to the screening of crude venom. The fractions with strongest cytotoxic effect on the triple negative MDA-MB-231 breast cancer cells are shown above.
